Association Of Neuropathic Pain Improvement And hs-CRP Changes Among Trigeminal Neuralgia Patients Experienced Radiofrequency Ablation 60o and 65o Celcius: 6 months follow up
DOI:
https://doi.org/10.36408/mhjcm.v10i2.876Keywords:
Trigeminal neuralgia, neuropathic pain, inflammation, LANSS score, Hs-CRPAbstract
INTRODUCTION: Trigeminal neuralgia (NT) is a neuropathic pain that involves the trigeminal nerve in the face. The first-line medical management of patients with NT is Carbamazepine (CBZ). Radiofrequency ablation (RFA) procedure is a minimally invasive procedure using a high-frequency current-generating device that produced heat ablate of C-fibers with effectiveness around 76% for 10 yeas follow-up. Inflammed trigeminal nerve (TG) or the branch(es) might be one of the underlying mechanisms unless vascular compression is a common etiology. The heat effects might be according to the temperature set up varies recently from 60°C to 95°C.
METHOD: This observational study enrolled 75 severe NT subjects without satisfactory improvement of treatments, divided into 3 groups: analgesics prescription (Control), RFA 60, and RFA 65 Groups. The LANSS scores and hs-CRP levels were followed-up before (baseline), 2 weeks, 3, and 6 months experienced the treatments. Subjects ages in the range of 48.32 + 12.73 to 50.88 + 14.59 years old, and the duration of illness from 4.48 to 10.32 months.
RESULT: The LANSS score >12 before treatments showed significance improvements (p<0.001), as in the Control (64% with neuropathic pain), RFA 60 (100% with neuropathic pain), and RFA 65 group (92% with nociceptive pain) at 2 weeks followed-up. At 3 and 6 months observed 100% subjects with nociceptive pain but without significancies. Even though the hs-CRP levels observed reduced for all groups, especially RFA 60 and RFA 65, but have no significances.
CONCLUSION: The LANSS scores changes observed significant improvement in all groups, which mentioned if the neuropathic pain syndromes might be better under each treatment. The Hs-CRP levels improvement is better in the neuro ablation groups than analgesic drugs treatment. Even though the Hs-CRP are following of systemic nonspecific inflammation, NT is a focal inflammation.
Downloads
References
1. Bendtsen L, Zakrzewska JM, Heinskou TB, Hodaie M, Leal PRL, Nurmikko T, et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 2020 Sep;19(9):784–96. DOI: https://doi.org/10.1016/S1474-4422(20)30233-7
2. Neto HS, Camilli JA, Marques MJ. Trigeminal neuralgia is caused by maxillary and mandibular nerve entrapment: Greater incidence of right-sided facial symptoms is due to the foramen rotundum and foramen ovale being narrower on the right side of the cranium. Med Hypotheses. 2005 Jan; 65(6): 1179–82. DOI: https://doi.org/10.1016/j.mehy.2005.06.012
3. Cruccu G, Finnerup NB, Jensen TS, Scholz J, Sindou M, Svensson P, et al. Trigeminal neuralgia. Neurology. 2016 Jul 12; 87(2): 220–8. DOI: https://doi.org/10.1212/WNL.0000000000002840
4. Vasappa CK, Kapur S, Krovvidi H. Trigeminal neuralgia. BJA Educ. 2016; 16(10): 353–6. DOI: https://doi.org/10.1093/bjaed/mkw015
5. Al-Quliti KW. Update on neuropathic pain treatment for trigeminal neuralgia. Neurosciences. 2015 Apr 13; 20(2): 107–14. DOI: https://doi.org.10.17712/nsj.2015.2.20140501
6. Ono Y, Shimo T, Shirafuji Y, Hamada T, Masui M, Obata K, et al. Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia. Case Rep Dent. 2016; 2016:1–4. DOI: https://doi.org/10.1155/2016/4605231
7. Alkazaz ZA, Faisal IM, Merkhan MM, Almukhtar HM, Khalaf HM, Zainal AA, et al. Efficacy of drugs for classical trigeminal neuralgia; statistical study comparative to gold-standard carbamazepine. https://doi.org/10.24271/garmian.scpas26
8. McMillan R, Zakrzewska J, Bahra A, Beecroft E, Besi E, Chong S, et al. Guidelines for the management of trigeminal neuralgia 2021. Faculty of Dental Surgery of the Royal College of Surgeons of England. https://www.rcseng.ac.uk/-/media/files/rcs/fds/guidelines/trigemina-neuralgia-guidelines_2021_v4.pdf
9. Chaves JPG, Fernandes De Oliveira TVG, Francisco AN, de Oliveira Trintinalha M, Pádua Carvalho NV. Trigeminal neuralgia recurrence: a comparison of microvascular decompression and percutaneous balloon compression: a five years follow-up study. Arq Neuropsiquiatr. 2021; 79(1): 51-5. https://doi.org/10.1590/0004-282X-anp-2020-0115
10. Li CS, Liu JT, Chang CS, Liao WJ. Atheromatous plaque formation in a man with high-risk atherosclerosis after Gamma Knife stereotactic radiosurgery for trigeminal neuralgia. Tzu Chi Medical Journal. 2015; 27: 181-3. DOI: http://dx.doi.org/10.1016/j.tcmj.2014.06.002
11. Huang Q, Liu X, Chen J, Bao C, Liu D, Fang Z, et al. The Effectiveness and Safety of Thermocoagulation Radiofrequency Treatment of the Ophthalmic Division (V1) and/or Maxillary (V2) and Mandibular (V3) Division in Idiopathic Trigeminal Neuralgia: An Observational Study. Pain Physician. 2016; 19: E1041-E1047. DOI: https://10.36076/ppj/2016.19.E1041
12. Wu H, Zhou J, Chen J, Gu Y, Shi L, Ni H. Therapeutic efficacy and safety of radiofrequency ablation for the treatment of trigeminal neuralgia: a systematic review and meta-analysis. Journal of Pain Research. 2019:12 423–41. DOI: https://doi.org/10.2147/JPR.S176960
13. Park D, Chang MC.The mechanism of action of pulsed radiofrequency in reducing pain: a narrative review. J Yeungnam Med Sci 2022;39(3):200-205. https://doi.org/10.12701/jyms.2022.00101
14. Pihut M, Ceranowicz P, Gala A. Evaluation of C-Reactive Protein Level in Patients with Pain Form of Temporomandibular Joint Dysfunction. Pain Res Manag. 2018;2018:1–5. https://doi.org/10.1155/2018/7958034
15. Lencioni R, Cioni D, Lera J, Rocchi E, Pina CD, Crocetti L.Radiofrequency Ablation: Principles and Techniques. http://eknygos.lsmuni.lt/springer/159/307-315.pdf
16. Wang X qing, lv B, Wang H fen, Zhang X, Yu S yuan, Huang X sheng, et al. Lamotrigine-induced severe cutaneous adverse reaction: Update data from 1999–2014. Journal of Clinical Neuroscience. 2015 Jun; 22(6):1005–11. J Clin Neurosci. 2015 Jun;22(6):1005-11. DOI: https://doi.org/10.1016/j.jocn.2015.01.016
17. Yao P, Hong T, Wang Z bin, Ma J ming, Zhu Y qiang, Li H xi, et al. Treatment of bilateral idiopathic trigeminal neuralgia by radiofrequency thermocoagulation at different temperatures. Medicine. 2016; 95: 29(e4274). DOI: http://dx.doi.org/10.1097/MD.0000000000004274
18. Budisulistyo T, Arlina Y. Single cycle, low temperature radiofrequency ablation is effective for trigeminal neuralgia. Anaesthesia, Pain & Intensive Care. 2022; 26(5): 669-73. DOI: https://doi.org/10.35975/apic.v26i5.2024
19. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001 May;92(1):147–57. DOI: https://doi.org/10.1016/S0304-3959(00)00482-6
20. Pihut M, Ceranowicz P, Gala A. Evaluation of C-Reactive Protein Level in Patients with Pain Form of Temporomandibular Joint Dysfunction. Hindawi Pain Research and Management. 2018; Volume 2018. Article ID 7958034. DOI: https://doi.org/10.1155/2018/7958034
21. Yao Y, Chang B, Li S. Relationship of Inflammation with Trigeminal Neuralgia: A Cohort Study. The Journal of Craniofacial Surgery. 2019. DOI: https://doi.org/10.1097/SCS.0000000000005879
22. Avci AY, Lakadamyali H, Arikan S, Benli US, Kilinc M. High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients. The Journal of Headache and Pain. 2015; 16:9. http://www.thejournalofheadacheandpain.com/content/16/1/9
23. Banafa A, Sipilä K, Suvisaari J, Suominen AL. Low-grade inflammation as a potential mediator between depressive symptoms and temporomandibular pain: an 11-year follow-up study on Finnish adults. Acta Odontol Scand. 2021 Oct; 79(7): 545-53. DOI: https://doi.org/10.1080/00016357.2021.1909746
24. Pihut M, Ceranowicz P, Gala A. Evaluation of C-Reactive Protein Level in Patients with Pain Form of Temporomandibular Joint Dysfunction. Pain Res Manag. 2018 Apr 8; 2018: 7958034. DOI: https://doi.org/10.1155/2018/7958034
25. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D’Agostino RB, et al. Gender and C-reactive protein: Data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. 2006 Sep;152(3):593-8. DOI: https://doi.org/10.1016/j.ahj.2006.02.015
26. Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments. Gambeta E, Chichorro JG, Zamponi GW. Molecular Pain. 2020; Volume 16: 1–18. DOI: https://doi.org/10.1177/1744806920901890
27. Katheriya G, Chaurasia A, Khan N, Iqbal J. Prevalence of trigeminal neuralgia in Indian population visiting a higher dental care center in North India. Natl J Maxillofac Surg 2019;10:195-9. DOI: https://doi.org/10.4103/njms.NJMS_64_18
28. Kress B, Schindler M, Rasche D. Why Do Advanced Age and Female Gender Predispose to Trigeminal Neuralgia? Clinical Neuroradiology. 2008; 18(1):60-64 DOI: https://doi.org/10.1007/s00062-008-8007-7
29. Legato MJ. Gender-specific medicine in the genomic era. Clin Sci (Lond). 2016 Jan;130(1):1-7. DOI: https://doi.org/10.1042/CS20150551
30. Pieretti S, Giannuario A, Giovannandrea R, Marzoli F, Piccaro G, Minosi P, et al. Gender differences in pain and its relief. Ann Ist Super Sanita. 2016 Apr-Jun; 52(2): 184-9. DOI: https://doi.org/10.4415/ANN_16_02_09
31. Cheng J, Long J, Hui X, Lei D, Zhang H. Effects of microvascular decompression on depression and anxiety in trigeminal neuralgia: A prospective cohort study focused on risk factors and prognosis. Clin Neurol Neurosurg. 2017 Oct; 161: 59-64. DOI: https://doi.org/10.1016/j.clineuro.2017.08.011
32. Archey M, Goldey K, Crockett E, Boyette-Davis J. An Investigation of the Effects of Testosterone and Behavioral Expressions of Pain on Sex/Gender Differences in Pain Perception. Psychol Rep. 2019 Jun;122(3): 826- 40. DOI: https://doi.org/10.1177/0033294118781320
33. Tang YZ, Yang LQ, Yue JN, Wang XP, He LL, Ni JX. The optimal radiofrequency temperature in radiofrequency thermocoagulation for idiopathic trigeminal neuralgia. Medicine. 2016; 95: 28(e4103). DOI: http://dx.doi.org/10.1097/MD.0000000000004103
34. Jin HS, Shin JY, Kim YC, Lee SC, Choi EJ, Lee PB, et al. Predictive Factors Associated with Success and Failure for Radiofrequency Thermocoagulation in Patients with Trigeminal Neuralgia. Pain Physician. 2015 Nov; 18(6): 537–45.
35. Doshi P, Parikh N. Radio-frequency ablation of trigeminal ganglion for refractory pain of bilateral trigeminal neuralgia in a patient with multiple sclerosis. Indian Journal of Pain. 2018; 32(2): 113. DOI: https://doi.org/10.4103/ijpn.ijpn_42_18
36. Guo Z, Wu B, Du C, Cheng M, Tian Y. Stereotactic Approach Combined with 3D CT Reconstruction for Difficult-to-Access Foramen Ovale on Radiofrequency Thermocoagulation of the Gasserian Ganglion for Trigeminal Neuralgia. Pain Med. 2016 Sep;17(9):1704-16. DOI: https://doi.org/10.1093/pm/pnv108
37. Bharti N, Sujith J, Singla N, Panda NB, Bala I. Radiofrequency Thermoablation of the Gasserian Ganglion Versus the Peripheral Branches of the Trigeminal Nerve for Treatment of Trigeminal Neuralgia: A Randomized, Control Trial. Pain Physician. 2019;22(2):147–54. https://pubmed.ncbi.nlm.nih.gov/30921978/
38. Ding Y, Li H, Hong T, Zhu Y, Yao P, Zhou G. Combination of Pulsed Radiofrequency with Continuous Radiofrequency Thermocoagulation at Low Temperature Improves Efficacy and Safety in V2/V3 Primary Trigeminal Neuralgia. Pain Physician. 2018; 21(5): E545–53. https://www.painphysicianjournal.com/current/pdf?article=NTYxNg%3D%3D&journal=113
39. Rapisarda A, Baroni S, Gentili V, Moretti G, Burattini B, Sarlo F, et al. The role of biomarkers in drug-resistant trigeminal neuralgia: a prospective study in patients submitted to surgical treatment. Neurol Sci. 2022 Jul;43(7):4425-4430. DOI: https://doi.org/10.1007/s10072-022-05971-7
40. Hagen K, Stovner LJ, Zwart JA. High sensitivity C-reactive protein and risk of migraine in a 11-year follow-up with data from the Nord-Trøndelag health surveys 2006–2008 and 2017–2019.. The Journal of Headache and Pain (2020) 21:67. DOI: https://doi.org/10.1186/s10194-020-01142-1
41. Costa GMF, de Almeida Leite CM. Trigeminal neuralgia: peripheral and central mechanisms Rev Dor. São Paulo, 2015 oct-dec;16(4):297-301. DOI: https://doi.org/10.5935/1806-0013.20150061
42. Gürger M, Atescelik M, Yilmaz M, Yildiz M, Kalayci H, Kobat MA, et al. Can we define migraine patients with blood high-sensitivity C-reactive protein and galectin-3 levels in the emergency department? Arch Med Sci 2018; 14, 2: 307–12. DOI: https://doi.org/10.5114/aoms.2016.60984
43. Cosman ER, Dolensky JR, Hoffman RA. Factors That Affect Radiofrequency Heat Lesion Size. Pain Medicine. 2014; 15: 2020–36. DOI: https://doi.org/10.1111/pme.12566
44. Yao Y, Chang B, Li S. Relationship of Inflammation with Trigeminal Neuralgia: A Cohort Study. The Journal of Craniofacial Surgery. 2019. DOI: https://doi.org/10.1097/SCS.0000000000005879
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2023 Yani Arlina, Trianggoro Budisulistyo, Dwi Pudjonarko, Dodik Tugasworo, Herlina Suryawati, Elta Diah Pasmanasari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
